Recombinant interleukin 2 (IL-2) promotes T cell line-mediated neuroautoimmune disease

This publication has 11 references indexed in Scilit:

• Inhibition of rat autoimmune T cell activation by monoclonal antibodies
  Journal of Neuroimmunology, 1986
• Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells
  Nature, 1984
• Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2
  Science, 1984
• Augmentation of human natural cell-mediated cytotoxicity by recombinant human interleukin 2.
  The Journal of Immunology, 1984
• Induction of suppressor T cells by interleukin 2.
  The Journal of Immunology, 1984
• Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
  The Journal of Immunology, 1984
• The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.
  The Journal of Immunology, 1984
• Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells.
  The Journal of Immunology, 1982
• Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.
  The Journal of Experimental Medicine, 1982
• Rat dendritic cells function as accessory cells and control the production of a soluble factor required for mitogenic responses of T lymphocytes.
  Proceedings of the National Academy of Sciences, 1980